NCT02869256

Brief Summary

It will be a centralized database , multicentre (6 centers) , regional, chronic myelogenous leukemia cases of registration (CML) prospectively and retrospectively.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
400

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2014

Longer than P75 for all trials

Geographic Reach
1 country

6 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2014

Completed
2.6 years until next milestone

First Submitted

Initial submission to the registry

August 9, 2016

Completed
7 days until next milestone

First Posted

Study publicly available on registry

August 16, 2016

Completed
7.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2024

Completed
Last Updated

November 21, 2017

Status Verified

November 1, 2017

Enrollment Period

10 years

First QC Date

August 9, 2016

Last Update Submit

November 17, 2017

Conditions

Chronic Myeloid Leukemia

Keywords

chronic myeloid leukemiapractices evaluation

Outcome Measures

Primary Outcomes (1)

  • compliance of the management of patients with chronic myeloid leukemia compared to the guidelines

    10 years

Secondary Outcomes (1)

  • overall survival

    10 years

Interventions

Practices evaluationOTHER

Practices evaluation

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patient with chronic myeloid leukemia diagnosis in chronic phase

You may qualify if:

  • chronic myeloid leukemia Diagnosis (CML) in chronic phase , accelerated or blast
  • male or female patient aged 18 years or more
  • Cases transmitted by referring hematologist , one of the 6 participating centers after patient's oral information
  • Clinical record presented Concertation Meeting LMC Multidisciplinary coordinated by the Institute Bergonié

You may not qualify if:

  • none

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (6)

Polyclinique Bordeaux Nord

Bordeaux, 33000, France

RECRUITING

Centre Hospitalier Universitaire de Bordeaux

Bordeaux, 33076, France

RECRUITING

Institut Bergonié

Bordeaux, France

RECRUITING

Centre Hospitalier Universitaire de Dax

Dax, 40100, France

RECRUITING

Centre hospitalier Libourne

Libourne, France

RECRUITING

Centre Hospitalier Universitaire de Pau

Pau, 64000, France

RECRUITING

MeSH Terms

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Condition Hierarchy (Ancestors)

Leukemia, MyeloidLeukemiaNeoplasms by Histologic TypeNeoplasmsMyeloproliferative DisordersBone Marrow DiseasesHematologic DiseasesHemic and Lymphatic DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Central Study Contacts

Gabriel etienne, MD

CONTACT

G.Etienne@bordeaux.unicancer.fr

Simone Mathoulin-Pelissier, MD PhD

CONTACT

S.Mathoulin@bordeaux.unicancer.fr

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 9, 2016

First Posted

August 16, 2016

Study Start

January 1, 2014

Primary Completion

January 1, 2024

Study Completion

January 1, 2024

Last Updated

November 21, 2017

Record last verified: 2017-11

Data Sharing

IPD Sharing
Will not share

Locations

FR(6)